CHERTSEY, England, November 7, 2013 /PRNewswire/ --
Lord Robert Winston to chair
THE ASTELLAS INNOVATION DEBATE 2013
The Age Crunch - facts, fears and the future
Royal Institution of Great Britain, Tuesday 19th November 2013, 7pm
To be webcast live:http://www.innovationdebate.com
Scientist, medical doctor, broadcaster and politician Lord Robert Winston will be chairing a panel of internationally recognised experts for the 2nd Astellas Innovation Debate: The Age Crunch - facts, fears and the future, taking place on 19th November at the Royal Institution of Great November last year and focusing on how to nurture the scientific innovators of the future, this year's debate moves the spotlight from young scientists to the ageing population - an issue of decisive and urgent importance.
Watch the video of Lord Robert Winston explaining why we need to address the challenges an ageing population presents.
Lord Winston will chair a panel of experts including Nobel prize-winning biologist, Dr Elizabeth Blackburn; campaigner and politician Baroness Sally Greengross; Professor Tom Kirkwood CBE, Dean for Ageing, Institute for Ageing and Health, Newcastle University and Professor John Appleby, Chief Economist at the King's Fund. They will explore Britain. Following the success of the inaugural Astellas Innovation Debate, staged at the Royal Society in
the role of innovation as society faces critical challenges resulting from an ageing population, with the discussions centring on:
- How best can we support older people in the UK and Europe?
- How to rethink our approach to welfare and healthcare to tackle the major age-associated diseases
- How will an ageing society be funded, and whose responsibility should it be?
- How can innovation help society to value older people and help older people to make an active contribution?
Lord Robert Winston, Professor of Science and Society and Emeritus Professor of Fertility Studies at Imperial College London, commented:
"Over the last 150 years, improved standards of living and advances in medical science have doubled our life expectancy. Today, with people in affluent countries expecting to live well into their 80s, life expectancy is increasing by more than five hours a day for every day we live. This is a remarkable achievement and should be cause for celebration. But our older populations have health and welfare needs, and these needs are likely to grow. At the Astellas Innovation Debate 2013, we will explore how we might rethink our approach to welfare and healthcare, and we will ask what role scientific ingenuity can play in an ageing society, turning old age into a new age."
The aim of the Astellas Innovation Debate 2013 will be to explore, through thought-provoking discussion, how we can drive economic and social transformation by celebrating the over-65s - as workers, volunteers and carers, consumers and investors.
For further information, visit our website http://www.innovationdebate.com, or join the debate on Twitter @innovatedebate #AgeCrunch
Notes to editors
The Astellas Innovation Debate is to be chaired by Lord Robert Winston, Professor of Science and Society and Emeritus Professor of Fertility Studies at Imperial College London.
Confirmed panelists include:
Professor John Appleby Chief Economist at the King's Fund since 1998 and a visiting professor at the Department of Economics at City University, London
Dr Elizabeth Blackburn Morris Herzstein Professor in Biology and Physiology in the Department of Biochemistry and Biophysics at the University of California, San Francisco,
Nobel Prize winner in Physiology of Medicine in 2009 and a leader in the area of telomere and telomerase research.
Baroness Sally Greengross A crossbench (independent) member of the House of Lords since 2000 and chair of five All-Party Parliamentary Groups, Chief Executive of the International Longevity Centre (ILC) - UK; Co-President of the ILC Global Alliance.
Professor Tom Kirkwood Dean for Ageing & Director of Newcastle Initiative on Changing Age (NICA) at the University of Newcastle.
About The Astellas Innovation Debate
The Astellas Innovation Debate, organised and funded by Astellas Pharma Europe Ltd., explores the role of innovation in modern society.
This year's event, The Age Crunch: Facts fears and the future, at the Royal Institution of Great Britain on 19th November 2013, is bringing together influential and respected figures from the worlds of science, government, medicine, economics, industry and the media as they tackle the major issues surrounding scientific innovation today and tomorrow. The aim of The Innovation Debate is to air crucial issues, draw positive conclusions and to move the agenda forward.
Everyone - professionals in science, medicine and industry, and the general public - will have the opportunity to engage with The Astellas Innovation Debate through online media which will take discussions far beyond the walls of the Royal Institution of Great Britain.
The inaugural Innovation Debate at The Royal Society in London in November 2012, focused on innovation in a time of austerity and nurturing the innovators of the future. Under the chairmanship of Professor Jim Al-Khalili it brought together panellists such as Nobel laureate Professor Sir Andre Geim, physicist Professor Brian Cox and Professor Mariana Mazzucato, Professor in Economics at the University of Sussex.
About Astellas Pharma Europe Ltd.
Astellas Pharma Europe Ltd., located in the UK, is the European headquarters of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceuticals. The organisation's focus is to deliver outstanding R&D and marketing to continue growing in the world pharmaceutical market. Astellas Pharma Europe Ltd. is responsible for 21 affiliate offices located across Europe, the Middle East and Africa, an R&D site and three manufacturing plants. The company employs approximately 4,350 staff across these regions. For more information about Astellas Pharma Europe, please visit http://www.astellas.eu.
SOURCE Astellas Pharma Europe Ltd